| Product Code: ETC13261151 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Infectious Disease Testing Products Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Infectious Disease Testing Products Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Infectious Disease Testing Products Market Revenues & Volume, 2021 & 2031F |
3.3 North America Infectious Disease Testing Products Market - Industry Life Cycle |
3.4 North America Infectious Disease Testing Products Market - Porter's Five Forces |
3.5 North America Infectious Disease Testing Products Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Infectious Disease Testing Products Market Revenues & Volume Share, By Product and Services, 2021 & 2031F |
3.7 North America Infectious Disease Testing Products Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.8 North America Infectious Disease Testing Products Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.9 North America Infectious Disease Testing Products Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 North America Infectious Disease Testing Products Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Infectious Disease Testing Products Market Trends |
6 North America Infectious Disease Testing Products Market, 2021 - 2031 |
6.1 North America Infectious Disease Testing Products Market, Revenues & Volume, By Product and Services, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Infectious Disease Testing Products Market, Revenues & Volume, By Assays, 2021 - 2031 |
6.1.3 North America Infectious Disease Testing Products Market, Revenues & Volume, By Kits, 2021 - 2031 |
6.1.4 North America Infectious Disease Testing Products Market, Revenues & Volume, By Reagents, 2021 - 2031 |
6.1.5 North America Infectious Disease Testing Products Market, Revenues & Volume, By Instruments, 2021 - 2031 |
6.1.6 North America Infectious Disease Testing Products Market, Revenues & Volume, By Services and Software, 2021 - 2031 |
6.2 North America Infectious Disease Testing Products Market, Revenues & Volume, By Technology, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Infectious Disease Testing Products Market, Revenues & Volume, By Immunodiagnostics, 2021 - 2031 |
6.2.3 North America Infectious Disease Testing Products Market, Revenues & Volume, By Clinical Microbiology, 2021 - 2031 |
6.2.4 North America Infectious Disease Testing Products Market, Revenues & Volume, By Polymerase Chain Reaction, 2021 - 2031 |
6.2.5 North America Infectious Disease Testing Products Market, Revenues & Volume, By Isothermal Nucleic Acid Amplification Technology, 2021 - 2031 |
6.2.6 North America Infectious Disease Testing Products Market, Revenues & Volume, By DNA Sequencing and Next-Generation Sequencing, 2021 - 2031 |
6.2.7 North America Infectious Disease Testing Products Market, Revenues & Volume, By DNA Microarray, 2021 - 2031 |
6.2.8 North America Infectious Disease Testing Products Market, Revenues & Volume, By Other Technologies, 2021 - 2031 |
6.3 North America Infectious Disease Testing Products Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Infectious Disease Testing Products Market, Revenues & Volume, By Hepatitis, 2021 - 2031 |
6.3.3 North America Infectious Disease Testing Products Market, Revenues & Volume, By Human Immunodeficiency Virus, 2021 - 2031 |
6.3.4 North America Infectious Disease Testing Products Market, Revenues & Volume, By Chlamydia Trachomatis Genital Infection and Gonorrhea, 2021 - 2031 |
6.3.5 North America Infectious Disease Testing Products Market, Revenues & Volume, By Hospital-Acquired Infections, 2021 - 2031 |
6.3.6 North America Infectious Disease Testing Products Market, Revenues & Volume, By Human Papillomavirus, 2021 - 2031 |
6.3.7 North America Infectious Disease Testing Products Market, Revenues & Volume, By Tuberculosis, 2021 - 2031 |
6.3.8 North America Infectious Disease Testing Products Market, Revenues & Volume, By Influenza, 2021 - 2031 |
6.3.9 North America Infectious Disease Testing Products Market, Revenues & Volume, By Others, 2021 - 2031 |
6.4 North America Infectious Disease Testing Products Market, Revenues & Volume, By End-User, 2021 - 2031 |
6.4.2 North America Infectious Disease Testing Products Market, Revenues & Volume, By Hospitals/clinical laboratories, 2021 - 2031 |
6.4.3 North America Infectious Disease Testing Products Market, Revenues & Volume, By Reference laboratories, 2021 - 2031 |
6.4.4 North America Infectious Disease Testing Products Market, Revenues & Volume, By Physician offices, 2021 - 2031 |
6.4.5 North America Infectious Disease Testing Products Market, Revenues & Volume, By Academic/research institutes, 2021 - 2031 |
6.4.6 North America Infectious Disease Testing Products Market, Revenues & Volume, By Other end-users, 2021 - 2031 |
7 North America Infectious Disease Testing Products Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Infectious Disease Testing Products Market, Revenues & Volume, By Product and Services, 2021 - 2031 |
7.2.1 United States (US) Infectious Disease Testing Products Market, Revenues & Volume, By Product and Services, 2021 - 2031 |
7.2.2 Canada Infectious Disease Testing Products Market, Revenues & Volume, By Product and Services, 2021 - 2031 |
7.2.3 Rest of North America Infectious Disease Testing Products Market, Revenues & Volume, By Product and Services, 2021 - 2031 |
7.3 North America Infectious Disease Testing Products Market Revenues & Volume Share, By Technology, 2021 & 2031F |
7.3.1 United States (US) Infectious Disease Testing Products Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.3.2 Canada Infectious Disease Testing Products Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.3.3 Rest of North America Infectious Disease Testing Products Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.4 North America Infectious Disease Testing Products Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
7.4.1 United States (US) Infectious Disease Testing Products Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
7.4.2 Canada Infectious Disease Testing Products Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
7.4.3 Rest of North America Infectious Disease Testing Products Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
7.5 North America Infectious Disease Testing Products Market, Revenues & Volume, By End-User, 2021 - 2031 |
7.5.1 United States (US) Infectious Disease Testing Products Market, Revenues & Volume, By End-User, 2021 - 2031 |
7.5.2 Canada Infectious Disease Testing Products Market, Revenues & Volume, By End-User, 2021 - 2031 |
7.5.3 Rest of North America Infectious Disease Testing Products Market, Revenues & Volume, By End-User, 2021 - 2031 |
8 North America Infectious Disease Testing Products Market Key Performance Indicators |
9 North America Infectious Disease Testing Products Market - Export/Import By Countries Assessment |
10 North America Infectious Disease Testing Products Market - Opportunity Assessment |
10.1 North America Infectious Disease Testing Products Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Infectious Disease Testing Products Market Opportunity Assessment, By Product and Services, 2021 & 2031F |
10.3 North America Infectious Disease Testing Products Market Opportunity Assessment, By Technology, 2021 & 2031F |
10.4 North America Infectious Disease Testing Products Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
10.5 North America Infectious Disease Testing Products Market Opportunity Assessment, By End-User, 2021 & 2031F |
11 North America Infectious Disease Testing Products Market - Competitive Landscape |
11.1 North America Infectious Disease Testing Products Market Revenue Share, By Companies, 2022 |
11.2 North America Infectious Disease Testing Products Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here